Clinical Trials

NICE Endorses GSK's Blenrep Combo for Multiple Myeloma
Management & Regulatory NICE Endorses GSK's Blenrep Combo for Multiple Myeloma

Multiple myeloma remains a formidable challenge in oncology, known for its relentless cycle of relapse and treatment resistance. This blood cancer, which originates in plasma cells within the bone marrow, continues to affect patients profoundly, with around 6,240 individuals diagnosed annually in

Bridging the Gap: Cardiologist Access Key to Heart Failure Survival
Research & Development Bridging the Gap: Cardiologist Access Key to Heart Failure Survival

Heart failure is emerging as a critical battlefield in modern medicine, with a striking gap in specialist care endangering patient survival. While cancer patients routinely receive oncological consultations, heart failure patients often lack consistent access to cardiologists. Research by French

Can Early Statin Therapy Transform Diabetes Care?
Tech & Innovation Can Early Statin Therapy Transform Diabetes Care?

Ivan Kairatov, a renowned figure in biopharmaceutical research, has been at the forefront of integrating technological innovations within the field. His recent study delves into the critical role of timely statin therapy in managing cardiovascular risks among diabetes patients. Today, we explore

U.S. States Lead Charge on Genetic Privacy Laws in 2025
Management & Regulatory U.S. States Lead Charge on Genetic Privacy Laws in 2025

The realm of genetic privacy has garnered profound attention from lawmakers in the United States as they confront unfolding challenges related to genetic information security and confidentiality. This year, legislative bodies have demonstrated a proactive stance on addressing pressing issues

Will Ibtrozi Become the New Standard for ROS1-Positive NSCLC?
Management & Regulatory Will Ibtrozi Become the New Standard for ROS1-Positive NSCLC?

Imagine facing the battle against a form of lung cancer so rare that it affects only about 2% of those diagnosed with non-small cell lung cancer (NSCLC). This is the reality for those with ROS1-positive NSCLC, a disease that could soon see transformative change with the approval of Nuvation Bio's

Facial Thermal Imaging AI – A Review
Tech & Innovation Facial Thermal Imaging AI – A Review

The world of healthcare diagnostics is witnessing an exciting transformation through the integration of facial thermal imaging with advanced artificial intelligence (AI). In a realm where precision is paramount, this technology promises a breakthrough by offering a non-invasive, real-time

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later